Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
N-Gems
AddedFeb 17, 2024
UpdatedJun 18, 2026
N-Gems

N-Gems

Closed

N-GEMS offers real-time, affordable hospital equipment tracking to boost efficiency and patient care.

HQ
New York, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

N-GEMS provides affordable, high-accuracy, real-time equipment tracking services for hospitals. Their mission is to reduce equipment downtime and loss, increase nurse efficiency, and improve patient care. They focus on the healthcare market, specifically targeting hospitals to enhance operational efficiency and patient outcomes.

N-GEMS has significantly impacted the healthcare sector by improving the management and utilization of hospital equipment. Their innovative tracking solutions have led to increased nurse productivity and better patient care, positioning them as a valuable partner in the healthcare industry.

N-Gems - Similar Companies

Opal HTM logo

Opal HTM

opalhtm.com

Ilerasoft logo

Ilerasoft

Digital Medical Tech logo

Digital Medical Tech

Enroute logo

Enroute

enroute.digital

Railmo logo

Railmo

Navv Systems logo

Navv Systems

Position Health logo

Position Health

Equip ID logo

Equip ID

equipid.com

gingerCube logo

gingerCube

gingercube.com

Edokonta logo

Edokonta

Neptune logo

Neptune

Barton's Brain logo

Barton's Brain

Equani logo

Equani

Nimbus Concepts logo

Nimbus Concepts

TaskUnite logo

TaskUnite

taskunite.com

N-Gems - Quick Facts

Who are N-Gems' competitors?

Companies similar to N-Gems include Opal HTM, Ilerasoft, Digital Medical Tech and Enroute.

When was N-Gems founded?

N-Gems was founded in 2017.

Where is N-Gems' headquarters located?

N-Gems' headquarters is located in New York, US.

When was N-Gems' last funding round?

N-Gems' most recent funding round was for $50k (USD) in December 2017.

How much has N-Gems raised to-date?

As of Dec 14, 2017, N-Gems has raised a total of $50k (USD).

N-Gems - Classification

Ownership
  • Private
Technology
  • IoT
  • RFID
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Hospital Equipment
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software